| Kamran Shah, MD | |
|
5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 | |
| (734) 712-8350 | |
| (775) 712-8351 |
| Full Name | Kamran Shah |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 19 Years |
| Location | 5333 Mcauley Dr, Ypsilanti, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841408689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 4301101678 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| St Joseph Mercy Chelsea | Chelsea, MI | Hospital |
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Huron Valley Radiology Pc | 2961466859 | 72 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
| Entity Name | Huron Valley Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659398519 PECOS PAC ID: 2961466859 Enrollment ID: O20041119000401 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
| Entity Name | Radadvantage A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376719666 PECOS PAC ID: 2163597899 Enrollment ID: O20150715000075 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
| Entity Name | Integrated Imaging Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700285335 PECOS PAC ID: 2567784408 Enrollment ID: O20200625000500 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
| Entity Name | X-ray Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770536815 PECOS PAC ID: 7315859832 Enrollment ID: O20220203002443 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kamran Shah, MD 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 Ph: (734) 712-8350 | Kamran Shah, MD 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197-1014 Ph: (734) 712-8350 |
News Archive
ZaBeCor Pharmaceuticals ("ZaBeCor" or the "Company") announced today the initiation of a Phase II clinical trial for its asthma drug candidate Excellair™, following the successful results of the Company's Phase I clinical trials. ZaBeCor is one of the first companies to deliver siRNA to the lung and one of the first to target asthma with siRNA.
Paragonix Technologies, Inc. today announced that the European Society for Organ Transplantation accepted for presentation an abstract describing the performance of the Sherpa Pak™ Cardiac Transport System during the upcoming 16th Congress of the European Society for Organ Transplantation to be held in Vienna, Austria from the 8th - 11th September 2013.
Chimpanzees rarely get cancer, or a variety of other diseases that commonly arise in humans, but their genomic DNA sequence is nearly identical to ours. So, what's their secret? Researchers reporting in the September issue of the American Journal of Human Genetics, a Cell Press journal, have found that differences in certain DNA modifications, called methylation, might play a role.
Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
› Verified 4 days ago
Dr. Vishal Bhagat, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Dr. Gil S. Borlaza, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Oneil Lee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Owen Stark, Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8251 | |
Dr. Atif Siddiqi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 Fax: 734-712-8351 | |
Dr. Eva Bieniek, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197 Phone: 734-712-3456 Fax: 734-712-3456 | |
Paul Lee, Radiology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 6016, Ypsilanti, MI 48197 Phone: 734-712-8350 |